Stericycle: The Medical Waste Giant the DOJ Found Disposing of Regulated Pharmaceutical Waste in Violation of Environmental Law

Stericycle Inc., the largest medical waste disposal and compliance services company in the United States, reached a Department of Justice and Environmental Protection Agency consent decree resolving findings that the company had accepted regulated pharmaceutical waste and hazardous waste from healthcare generator clients and disposed of that material at treatment facilities that were not permitted under the Resource Conservation and Recovery Act to accept those waste streams — violations that the agencies found were systemic across the company's national network of treatment facilities rather than isolated to individual locations.DOCUMENTED

The Stericycle enforcement action addressed a market failure with significant environmental and public health implications: when the company trusted by healthcare facilities across the country to manage their regulated medical and pharmaceutical waste disposes of that waste improperly, the environmental controls that the RCRA permitting system is designed to maintain are bypassed, and the waste may end up in disposal pathways that cause groundwater contamination, air emissions, or other environmental harm that proper treatment would have prevented.

The Regulated Pharmaceutical Waste Challenge

Healthcare facilities generate substantial volumes of regulated pharmaceutical waste — including unused medications, expired drugs, controlled substance residuals, and pharmaceutical-contaminated materials — that must be managed in compliance with RCRA hazardous waste regulations and, for controlled substances, DEA requirements. The regulatory framework governing pharmaceutical waste disposal is complex: some pharmaceutical wastes are classified as listed hazardous wastes requiring management at permitted hazardous waste facilities; others qualify for management through permitted medical waste treatment systems; and still others can be disposed of through specific exemptions or alternative pathways that require documentation of the waste's characteristics.REVIEWED

Healthcare facilities that generate regulated pharmaceutical waste typically outsource its management to specialized disposal companies like Stericycle, relying on the disposal company's expertise and permitted facilities to ensure that the waste is handled in compliance with applicable regulations. When Stericycle accepted pharmaceutical waste streams and directed them to treatment facilities that were not permitted for those specific waste types, the healthcare generators — hospitals, clinics, pharmacies, and other medical facilities — were potentially unaware that their waste was not being handled in compliance with the disposal company's representations. The DOJ and EPA's findings created both direct enforcement against Stericycle and potential secondary liability concerns for healthcare generators who may not have received the compliant disposal services they believed they were purchasing.DOCUMENTED

Facility Permitting and Waste Acceptance Failures

RCRA treatment, storage, and disposal facility permits specify the waste streams that the facility is authorized to accept and treat. A medical waste autoclave — a high-pressure steam sterilization system — is permitted to treat pathological waste, sharps, and other infectious medical waste, but is not necessarily permitted to accept pharmaceutical wastes that require incineration or chemical treatment for proper destruction. When Stericycle accepted pharmaceutical waste from healthcare clients and routed it to autoclave facilities rather than to properly permitted pharmaceutical incineration or alternative treatment facilities, the waste was processed through a treatment method that may not have adequately destroyed the pharmaceutical compounds, potentially resulting in improper disposal of regulated substances in the solid waste stream.REVIEWED

The waste characterization failures at the heart of the Stericycle violations involved the company's processes for identifying the regulatory classification of incoming waste streams and routing them to appropriately permitted facilities. A company with Stericycle's market position — serving hospitals and healthcare systems across the country, accepting waste from thousands of generator clients — must maintain robust waste characterization systems to ensure that each waste stream is correctly classified and directed to a facility permitted for that classification. When those systems fail systematically — as the DOJ and EPA found they had across Stericycle's network — the resulting environmental and compliance harm occurs at the scale of the company's enormous market footprint.

When the largest medical waste company in the country routes pharmaceutical waste to the wrong facility, the compliance gap is not isolated to one hospital's back dock. It extends to every healthcare client in the network who trusted that the waste was going where it was supposed to go.

Environmental and Public Health Consequences

The improper disposal of regulated pharmaceutical waste through treatment systems not designed for those materials can have environmental consequences that vary by the specific waste involved and the treatment method used. Pharmaceutical compounds that are not adequately destroyed in an autoclave may enter the solid waste stream and ultimately the landfill environment, potentially contaminating leachate with active pharmaceutical ingredients that can reach groundwater if the landfill is not adequately engineered. Hormonal compounds, antibiotics, and other pharmaceutically active substances have been documented in groundwater in areas where pharmaceutical waste has been improperly disposed of, creating environmental persistence concerns that proper treatment at permitted incineration facilities would have addressed.DOCUMENTED

For the healthcare facilities that generated the waste, the improper disposal created potential RCRA generator liability — the principle that generators remain responsible for their waste from cradle to grave, even when they have contracted with a third-party disposal company. If the disposal company's non-compliant handling constitutes a RCRA violation, the generator may share liability depending on the specifics of the waste characterization, the generator's knowledge of the disposal method, and the contractual representations made by the disposal company. Healthcare compliance officers who learned of the Stericycle enforcement action had to assess whether their facilities' waste streams might have been among those affected and whether their generator compliance programs were adequate to demonstrate the due diligence the RCRA generator standard requires.

The Consent Decree Requirements

The DOJ and EPA consent decree required Stericycle to implement comprehensive improvements to its waste acceptance and characterization procedures across its national facility network — including enhanced training of facility staff in waste classification, documented waste acceptance criteria specifying which waste streams each facility was permitted to receive, upgraded tracking systems to verify that accepted waste was directed to appropriately permitted treatment facilities, and periodic compliance audits by independent environmental compliance professionals. The civil monetary penalties reflected both the scale of the violations and the company's market dominance — a firm that controls as much of the regulated medical waste market as Stericycle does is expected to lead the industry in regulatory compliance rather than trail it.REVIEWED

For healthcare clients, the Stericycle consent decree was a catalyst for reviewing waste disposal contracts and verification practices. Prudent healthcare compliance programs include periodic verification that disposal vendors' facilities are currently permitted for the waste streams being tendered, spot checks of waste manifests to confirm that accepted waste has been directed to the permitted facilities identified in the manifest, and contractual representations from disposal companies about compliance status that create contractual remedies if misrepresented. The lesson from the Stericycle case is that the healthcare generator's compliance obligations do not end at the point of tender to a disposal company — they extend to verifying that the disposal is actually occurring in compliance with the permits and regulatory requirements the contract represents.

Market Structure and Regulatory Incentives

Stericycle's dominant market position in regulated medical waste disposal creates a market structure in which its compliance practices set the de facto standard for the industry. When the market leader cuts corners on waste characterization and facility permitting compliance, it reduces its own costs in ways that create pressure on competitors who maintain compliant operations at higher cost — a dynamic that can gradually erode compliance standards across the industry as competitors face the competitive disadvantage of doing the more expensive right thing. The DOJ and EPA's enforcement against Stericycle addressed this dynamic directly: by imposing compliance requirements and penalties that reflect the full cost of compliance rather than the lower cost of non-compliance, the consent decree aims to restore the competitive advantage of proper compliance and to signal that market leadership does not insulate a company from the full application of environmental enforcement.

Have documents relevant to this story? Reach us through our tips channel.